Abstract:DOI:10.1097/COH.0000000000000291 Seven years ago, Hutter et al. [1] reported the unique case of a 40-year-old HIV-infected man who was cured of HIV infection following an allogeneic bone marrow transplant. Timothy Ray Brown, also known as the ‘Berlin Patient’ is until today the only person from whom HIV has been eradicated. This extraordinary and largely unexpected success fostered HIV cure research by opening novel therapeutic possibilities that could potentially surpass combination antiretroviral therapy (ART). Indeed, although ART has dramatically reduced the death rate from AIDS and improved the quality of life of many HIV-infected individuals, the possible longterm toxicity associated with ART, stigma and cost all contribute to the necessity of finding a cure. A ‘sterilizing cure’, in which the virus is completely eradicated, would require the elimination of all replication-competent viruses throughout the body. An alternative approach, probably more realistic, would be to aim for what we might consider a ‘cancer model’ of cure, in which an individual would enjoy long-term health in the absence of ART, with perhaps low-level viremia. This is commonly referred to as a ‘functional cure’ in which the viral reservoir is naturally controlled by the host. Both forms of cure (sterilizing and functional) would require eliminating, or at least reducing, the reservoirs of HIV infection. Since the report of the first HIV cure, the field of HIV reservoirs has evolved rapidly. Several strategies have been proposed to interfere with HIV persistence during ART. The development of these novel approaches has benefited from the tremendous progresses that have been made at the molecular level, including the key cellular viral and immunological mechanisms that regulate the magnitude of the persistent HIV reservoirs. This issue aims to address the challenges that should be overcome to develop a safe, scalable and affordable cure for HIV infection. Although it is well established that HIV persists in individuals receiving suppressive ART, the precise cellular and anatomical locations that are primarily responsible for HIV persistence are still debated. Yukl et al. (pp. 362–370) review studies describing tissue reservoirs by organ system with particular attention to the nature of the infected cell types in each compartment, evidence for viral

Best subspace tensor approximations

Decomposing tensors via rank-one approximations

On The Tensor Svd And The Optimal Low Rank Orthogonal Approximation Of Tensors

The number of singular vector tuples and uniqueness of best rank one approximation of tensors

On the rank and the approximation of symmetric tensors

Optimum Subspace Learning And Error Correction For Tensors

Better than best low-rank approximation with the singular value decomposition

Exact Tensor Completion Using T-Svd

A Randomized Algorithm for Tensor Singular Value Decomposition using an Arbitrary Number of Passes

Tensor Golub Kahan based on Einstein product

Optimal Sparse Singular Value Decomposition for High-dimensional High-order Data

Subtracting a best rank-1 approximation may increase tensor rank

Efficient Algorithms for Low Tubal Rank Tensor Approximation with Applications to Image Compression, Super-Resolution and Deep Learning

Low Rank Tensor Decompositions and Approximations

Efficient Alternating Least Squares Algorithms for Low Multilinear Rank Approximation of Tensors

Very Large-Scale Singular Value Decomposition Using Tensor Train Networks

Strategies for targeting residual HIV infection.

Singular Value Decomposition Approximation via Kronecker Summations for Imaging Applications

Tensor Neural Network Models for Tensor Singular Value Decompositions.

Low Rank Symmetric Tensor Approximations

Higher-order principal component analysis for the approximation of tensors in tree-based low-rank formats